Titibiev can effectively treat hepatitis B

two recent studies published by the University of Hong Kong and the University of Chinese of Hong Kong show that the new drug for the treatment of hepatitis B is more effective at suppressing the virus than two traditional drugsAt a joint press conference between the University of Hong Kong and the University of Chinese of Hong Kong, the results of the results of the new hepatitis B drug tribibdine and the combined drug ramivudine and Adfovirin were presentedIn both studies, more than 1,000 patients with chronic hepatitis B from around the world were involved, and the results showed that after a year of treatment, 60 per cent of patients taking tinpeddin had an undetectable level of the virus in their serum, compared with about 40 per cent of patients taking traditional drugsIn addition, tinbizin has fewer side effects and is less resistant than two traditional drugsProfessor Chen Liyuan, Director of the Centre for Liver Care at the School of Medicine of the Chinese School of Medicine in Hong Kong, said that the treatment of hepatitis B must be treated with safe and effective therapies as early as possible to significantly reduce the number of viruses(Smell)